BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32459745)

  • 1. MYO5B Pathogenic Variants Found to Cause Intestinal Symptoms Without Microvillus Inclusion Disease in a Child Who Previously Underwent Liver Transplantation for PFIC-like Cholestasis.
    Jarasvaraparn C; He M; Granadillo JL; Kulkarni S; Stoll J; Liss K
    J Pediatr Gastroenterol Nutr; 2021 Jan; 72(1):e22-e24. PubMed ID: 32459745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.
    Gonzales E; Taylor SA; Davit-Spraul A; Thébaut A; Thomassin N; Guettier C; Whitington PF; Jacquemin E
    Hepatology; 2017 Jan; 65(1):164-173. PubMed ID: 27532546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvillus inclusion disease with novel MYO5B pathogenic variants.
    Kwon R; Huang J; Oshima K; Warren M; Voltaggio L; Wang Y; Montgomery EA; Hutchings D
    Histopathology; 2021 Jul; 79(1):119-121. PubMed ID: 33544913
    [No Abstract]   [Full Text] [Related]  

  • 4. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.
    Girard M; Lacaille F; Verkarre V; Mategot R; Feldmann G; Grodet A; Sauvat F; Irtan S; Davit-Spraul A; Jacquemin E; Ruemmele F; Rainteau D; Goulet O; Colomb V; Chardot C; Henrion-Caude A; Debray D
    Hepatology; 2014 Jul; 60(1):301-10. PubMed ID: 24375397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unequal Effects of Myosin 5B Mutations in Liver and Intestine Determine the Clinical Presentation of Low-Gamma-Glutamyltransferase Cholestasis.
    van IJzendoorn SCD; Li Q; Qiu YL; Wang JS; Overeem AW
    Hepatology; 2020 Oct; 72(4):1461-1468. PubMed ID: 32583448
    [No Abstract]   [Full Text] [Related]  

  • 6. Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters.
    Engevik AC; Coutts AW; Kaji I; Rodriguez P; Ongaratto F; Saqui-Salces M; Medida RL; Meyer AR; Kolobova E; Engevik MA; Williams JA; Shub MD; Carlson DF; Melkamu T; Goldenring JR
    Gastroenterology; 2020 Jun; 158(8):2236-2249.e9. PubMed ID: 32112796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease.
    Knowles BC; Roland JT; Krishnan M; Tyska MJ; Lapierre LA; Dickman PS; Goldenring JR; Shub MD
    J Clin Invest; 2014 Jul; 124(7):2947-62. PubMed ID: 24892806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Functional Relationship Between UNC45A and MYO5B Connects Two Rare Diseases With Shared Enteropathy.
    Li Q; Zhou Z; Sun Y; Sun C; Klappe K; van IJzendoorn SCD
    Cell Mol Gastroenterol Hepatol; 2022; 14(2):295-310. PubMed ID: 35421597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview and online registry of microvillus inclusion disease patients and their MYO5B mutations.
    van der Velde KJ; Dhekne HS; Swertz MA; Sirigu S; Ropars V; Vinke PC; Rengaw T; van den Akker PC; Rings EH; Houdusse A; van Ijzendoorn SC
    Hum Mutat; 2013 Dec; 34(12):1597-605. PubMed ID: 24014347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal diagnosis of microvillus inclusion disease.
    Chen CP; Su YN; Chern SR; Wu PC; Wang W
    Taiwan J Obstet Gynecol; 2011 Sep; 50(3):399-400. PubMed ID: 22030065
    [No Abstract]   [Full Text] [Related]  

  • 11. Microvillus inclusion disease: loss of Myosin vb disrupts intracellular traffic and cell polarity.
    Thoeni CE; Vogel GF; Tancevski I; Geley S; Lechner S; Pfaller K; Hess MW; Müller T; Janecke AR; Avitzur Y; Muise A; Cutz E; Huber LA
    Traffic; 2014 Jan; 15(1):22-42. PubMed ID: 24138727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYO5B-associated diseases: Novel liver-related variants and genotype-phenotype correlation.
    Wang L; Qiu YL; Xu HM; Zhu J; Li SJ; OuYang WX; Yang YF; Lu Y; Xie XB; Xing QH; Wang JS
    Liver Int; 2022 Feb; 42(2):402-411. PubMed ID: 34811877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and MYO5B mutations of a family affected by microvillus inclusion disease].
    Cheng Y; Liang H; Cai NL; Guo L; Huang YG; Song YZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Sep; 19(9):968-974. PubMed ID: 28899465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of microvillus inclusion disease caused by MYO5B deficiency with prenatal abnormalities.
    Lu J; Qi Y; Ding H; Yin A
    Prenat Diagn; 2022 Jan; 42(1):136-140. PubMed ID: 34816459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of intestinal ion transport defects in microvillus inclusion disease.
    Kravtsov DV; Ahsan MK; Kumari V; van Ijzendoorn SC; Reyes-Mugica M; Kumar A; Gujral T; Dudeja PK; Ameen NA
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G142-55. PubMed ID: 27229121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phenotypic and genetic analysis of a family affected with microvillus inclusion disease].
    Mao M; Guo L; Zhang Z; Wang B; Huang S; Song Y; Chen F; Wen W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):792-796. PubMed ID: 27984607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model.
    Ruemmele FM; Müller T; Schiefermeier N; Ebner HL; Lechner S; Pfaller K; Thöni CE; Goulet O; Lacaille F; Schmitz J; Colomb V; Sauvat F; Revillon Y; Canioni D; Brousse N; de Saint-Basile G; Lefebvre J; Heinz-Erian P; Enninger A; Utermann G; Hess MW; Janecke AR; Huber LA
    Hum Mutat; 2010 May; 31(5):544-51. PubMed ID: 20186687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvilli as markers of disordered apical-membrane trafficking and assembly: bowel and liver.
    Thompson RJ; Knisely AS
    Hepatology; 2014 Jul; 60(1):34-6. PubMed ID: 24668851
    [No Abstract]   [Full Text] [Related]  

  • 19. Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease.
    Schlegel C; Weis VG; Knowles BC; Lapierre LA; Martin MG; Dickman P; Goldenring JR; Shub MD
    Dig Dis Sci; 2018 Feb; 63(2):356-365. PubMed ID: 29218485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myosin 5b loss of function leads to defects in polarized signaling: implication for microvillus inclusion disease pathogenesis and treatment.
    Kravtsov D; Mashukova A; Forteza R; Rodriguez MM; Ameen NA; Salas PJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G992-G1001. PubMed ID: 25258405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.